Cargando…

ODP156 A Case Report of Clomiphene induced Severe Hypertriglyceridemia

BACKGROUND: The effects of estrogen on lipids have been well studied whereby estrogen has been shown to decrease total cholesterol and low-density lipoprotein (LDL) cholesterol concentrations and increase high-density lipoprotein (HDL) cholesterol and triglyceride (TG) levels. On the other hand, the...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Zi, Ahmed, Ammar, Zainal, Abir, Bingham, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624612/
http://dx.doi.org/10.1210/jendso/bvac150.506
_version_ 1784822274179727360
author Tan, Zi
Ahmed, Ammar
Zainal, Abir
Bingham, Robert
author_facet Tan, Zi
Ahmed, Ammar
Zainal, Abir
Bingham, Robert
author_sort Tan, Zi
collection PubMed
description BACKGROUND: The effects of estrogen on lipids have been well studied whereby estrogen has been shown to decrease total cholesterol and low-density lipoprotein (LDL) cholesterol concentrations and increase high-density lipoprotein (HDL) cholesterol and triglyceride (TG) levels. On the other hand, the effects of clomiphene, a selective estrogen receptor modulator have not been well established. CLINICAL CASE: A 34-year-old woman with a significant history of type II diabetes who recently started taking self-prescribed clomiphene presented with epigastric pain, nausea, and vomiting. Abdominal examination revealed generalized abdominal tenderness. Laboratory testing revealed normal lipase (30 U/L, normal range 6-51 U/L), increased serum glucose (268 mg/dL, normal range 60-140 mg/dL), and significant elevated TG level (6576 mg/dL, normal range 0-149 mg/dL). Her TG level was 345 mg/dl five months prior to presentation. Abdominal ultrasonography was revealed with no evidence of gallstones and a heterogenous pancreas. She was treated with an insulin infusion and aggressive fluid resuscitation, and her TG level improved to 255 mg/dL after treatment. Given her recent clomiphene use, the patient was deemed to have developed clomiphene-induced severe hypertriglyceridemia. The patient was advised to stop further clomiphene indefinitely and was discharged with fenofibrate 145mg daily and fish oil i. e. omega-3 fatty acid 4g daily for her hypertriglyceridemia. She was asked to follow up with endocrinology outpatient after discharge; however, she was unfortunately lost to follow-up. CONCLUSION: This is a rare case report of hypertriglyceridemia caused by using clomiphene citrate. Serum lipid levels should be measured and followed up closely for patients having risk factors predisposing to hyperlipidemia while using clomiphene citrate. Reference: Castro, M. R., T. T. Nguyen, and T. O'Brien, Clomiphene-induced severe hypertriglyceridemia and pancreatitis. Mayo Clin Proc, 1999. 74(11): p. 1125-8. Presentation: No date and time listed
format Online
Article
Text
id pubmed-9624612
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-96246122022-11-14 ODP156 A Case Report of Clomiphene induced Severe Hypertriglyceridemia Tan, Zi Ahmed, Ammar Zainal, Abir Bingham, Robert J Endocr Soc Cardiovascular Endocrinology BACKGROUND: The effects of estrogen on lipids have been well studied whereby estrogen has been shown to decrease total cholesterol and low-density lipoprotein (LDL) cholesterol concentrations and increase high-density lipoprotein (HDL) cholesterol and triglyceride (TG) levels. On the other hand, the effects of clomiphene, a selective estrogen receptor modulator have not been well established. CLINICAL CASE: A 34-year-old woman with a significant history of type II diabetes who recently started taking self-prescribed clomiphene presented with epigastric pain, nausea, and vomiting. Abdominal examination revealed generalized abdominal tenderness. Laboratory testing revealed normal lipase (30 U/L, normal range 6-51 U/L), increased serum glucose (268 mg/dL, normal range 60-140 mg/dL), and significant elevated TG level (6576 mg/dL, normal range 0-149 mg/dL). Her TG level was 345 mg/dl five months prior to presentation. Abdominal ultrasonography was revealed with no evidence of gallstones and a heterogenous pancreas. She was treated with an insulin infusion and aggressive fluid resuscitation, and her TG level improved to 255 mg/dL after treatment. Given her recent clomiphene use, the patient was deemed to have developed clomiphene-induced severe hypertriglyceridemia. The patient was advised to stop further clomiphene indefinitely and was discharged with fenofibrate 145mg daily and fish oil i. e. omega-3 fatty acid 4g daily for her hypertriglyceridemia. She was asked to follow up with endocrinology outpatient after discharge; however, she was unfortunately lost to follow-up. CONCLUSION: This is a rare case report of hypertriglyceridemia caused by using clomiphene citrate. Serum lipid levels should be measured and followed up closely for patients having risk factors predisposing to hyperlipidemia while using clomiphene citrate. Reference: Castro, M. R., T. T. Nguyen, and T. O'Brien, Clomiphene-induced severe hypertriglyceridemia and pancreatitis. Mayo Clin Proc, 1999. 74(11): p. 1125-8. Presentation: No date and time listed Oxford University Press 2022-11-01 /pmc/articles/PMC9624612/ http://dx.doi.org/10.1210/jendso/bvac150.506 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the Endocrine Society. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Cardiovascular Endocrinology
Tan, Zi
Ahmed, Ammar
Zainal, Abir
Bingham, Robert
ODP156 A Case Report of Clomiphene induced Severe Hypertriglyceridemia
title ODP156 A Case Report of Clomiphene induced Severe Hypertriglyceridemia
title_full ODP156 A Case Report of Clomiphene induced Severe Hypertriglyceridemia
title_fullStr ODP156 A Case Report of Clomiphene induced Severe Hypertriglyceridemia
title_full_unstemmed ODP156 A Case Report of Clomiphene induced Severe Hypertriglyceridemia
title_short ODP156 A Case Report of Clomiphene induced Severe Hypertriglyceridemia
title_sort odp156 a case report of clomiphene induced severe hypertriglyceridemia
topic Cardiovascular Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624612/
http://dx.doi.org/10.1210/jendso/bvac150.506
work_keys_str_mv AT tanzi odp156acasereportofclomipheneinducedseverehypertriglyceridemia
AT ahmedammar odp156acasereportofclomipheneinducedseverehypertriglyceridemia
AT zainalabir odp156acasereportofclomipheneinducedseverehypertriglyceridemia
AT binghamrobert odp156acasereportofclomipheneinducedseverehypertriglyceridemia